We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Drugmakers Awarded $62 Million for Ebola Drug Development
Two Drugmakers Awarded $62 Million for Ebola Drug Development
The U.S. government is awarding $62 million to Regeneron Pharmaceuticals and Inovio Pharmaceuticals to support their ongoing development of novel Ebola virus treatments.